Site Search
Search Results
Victory for Public Health: ACS CAN Applauds Decision to Reject Flawed Biomarker Legislation
The following is a statement from Doug Hogan, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) applauds the Senate for not supporting House Bill 4753, the ... tests that can allow them to benefit from the right treatments at the right time – often leading to improved health outcomes, better quality of life, and ultimately cost savings – but this legislation fell short of those goals. “Biomarker testing and precision medicine are helping extend and improve lives ...
Delegate Westfall files legislation aimed at improving health outcomes in West Virginia
CHARLESTON, W. Va. –Delegate Steve Westfall recently introduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack of coverage by health insurance and Medicaid programs, which this legislation would fix. “This bill expands coverage of biomarker testing so more ...
2024 West Virginia Cancer Action Day Webpage
... shop for all the necessary resources to prepare for your participation in successful lawmaker conversations on February 12th. We know that part of the magic that goes into an impactful Cancer Action Day is preparation, coordination, and resources - coupled with our pre-event ... Recording 24_wv_volunteer_training_presentation_.pdf Biomarker Fact Sheets Mentioned in the Pre-Training: biomarker_testing_costs_and_cost_savings.pdf acs_can_biomarker_testing_patient_profiles_final_0.pdf health_equity_in_biomarker_testing_and_targeted_therapy_.pdf biomarker_testing_faq_.pdf ...
House Passes Legislation That Won’t Improve Health Outcomes
... The following is a statement from Doug Hogan, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) urges the Senate to amend House Bill 4753, the biomarker ... tests that can allow them to benefit from the right treatments at the right time – often leading to improved health outcomes, better quality of life, and ultimately cost savings – but this legislation falls short of those goals. “Biomarker testing and precision medicine are helping extend and improve ...